Invesco Ltd. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-10 11:32 am Sale | 2022-03-10 | 13G | Reata Pharmaceuticals, Inc. RETA | Invesco Ltd. IVZ | 372,165 1.200% | -1,908,244 (-83.68%) | Filing |
| 2022-02-10 11:32 am Sale | 2022-02-09 | 13G | Reata Pharmaceuticals, Inc. RETA | Invesco Ltd. IVZ | 2,280,409 7.200% | -1,157,169 (-33.66%) | Filing |
| 2021-09-10 10:22 am Purchase | 2021-09-10 | 13G | Reata Pharmaceuticals, Inc. RETA | Invesco Ltd. IVZ | 3,437,578 10.900% | 1,658,103 (+93.18%) | Filing |
| 2021-02-12 6:48 pm Purchase | 2021-02-12 | 13G | Reata Pharmaceuticals, Inc. RETA | Invesco Ltd. IVZ | 1,779,475 5.700% | 1,779,475 (New Position) | Filing |